Tuberculosis re-treatment after exclusion of rifampicin resistance
Eur Respir J
.
2018 Feb 14;51(2):1702282.
doi: 10.1183/13993003.02282-2017.
Print 2018 Feb.
Authors
Chen-Yuan Chiang
1
2
3
,
Arnaud Trébucq
4
Affiliations
1
International Union Against Tuberculosis and Lung Disease, Paris, France cychiang@theunion.org.
2
Division of Pulmonary Medicine, Dept of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
3
Division of Pulmonary Medicine, Dept of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
4
International Union Against Tuberculosis and Lung Disease, Paris, France.
PMID:
29444921
DOI:
10.1183/13993003.02282-2017
No abstract available
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents
Humans
Rifampin*
Tuberculosis, Multidrug-Resistant*
Substances
Antitubercular Agents
Rifampin